CATEGORIES

Industry News

LATEST

TRENDING

EDITORS CHOICE

“Investigational” Is Payer Code for “Coverage Denied”

Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.

Could a Rash be a Sign of Covid-19?

A new study adds to a growing body of evidence pointing to skin rash as a possible symptom of Covid-19 infection. A skin rash can occur

The Medika Life 50 – The Most Influential Voices in Health for 2022

Medika Life 50 Top Healthcare Voices of Influence for 2022. Engage with leading voices, amplify their reach and expand your network.

Ivermectin is NOT Hydroxychloroquine. Why is the FDA Ignoring a Potential Covid Treatment?

Ivermectin has shown promise as a potential treatment. It needs to be urgently evaluated under the guidance of the FDA